Market Summary | Major Indices | Market Movers
Market Sectors | A-Z Stock Listings | Mutual Funds
World Markets | CEO Wealthmeter | ETF Screener
Oil / Energy | Metals | Treasury Rates | Currencies
Calculators | My Watchlist | My Portfolio
      
  Symbol Lookup
AETERNA ZENTARIS Add to My Watchlist (NSDQ: AEZS) 

Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Aeterna Zentar 0.85 +0.01 (+0.59%) 44,300
Profile for AEZS
AETERNA ZENTARIS
1405 Parc-Technologique Blvd.
Quebec City, Quebec G1P 4P5
http://www.aeternazentaris.com

AEterna Zentaris Inc is a biopharmaceutical company focused on endocrine therapy and oncology with expertise in drug discovery, development and commercialization.
Headquarters for AEZS
Key Facts
Industry Health
Sector Pharmaceuticals
# of Employees 234
Shares Outstanding 63.1M
Market Cap 53.6M
Enterprise Value -
52-Week High $3.25
52-Week Low $0.32
P/E Ratio -
EPS -
Dividend -
Yield -
Key Executives
Dr. Eric Dupont Ph.D. Chairman
Prof. Dr. Jurgen Engel Ph.D. Executive Vice President, Chief Operating Officer
Gilles R. Gagnon President, Chief Executive Officer
Dr. Eckhard Gunther Ph.D. Vice President
Dr. Manfred Peukert Vice President
Dr. Matthias Rischer Ph.D. Vice President
Dennis Turpin Vice President, Chief Financial Officer
Mario Paradis Vice President, Secretary
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
close window
E-mail Article to a Friend